How Psychedelic-Assisted Therapy Promotes Post-Traumatic Growth
Discover how adding MDMA to your trauma treatment practice could improve and accelerate outcomes
A PTSD study published in the peer-reviewed medical journal, Nature Medicine, in May 2021 revealed 67% of participants treated with MDMA-assisted psychotherapy no longer met the diagnostic criteria for PTSD 18 weeks after baseline.
Those are impressive results in any field. But how does it work?
What makes this psychedelic medicine so incredibly effective, where standard treatment like antidepressants only work for some people some of the time?
In this 10-minute video, international expert on psychedelics Peter H. Addy, PhD, LPC, LMHC, reveals How Psychedelic-Assisted Therapy with MDMA Promotes Post-Traumatic Growth.
Discover how MDMA and other psychedelics can help treat mental health distress!
Those are impressive results in any field. But how does it work?
What makes this psychedelic medicine so incredibly effective, where standard treatment like antidepressants only work for some people some of the time?
In this 10-minute video, international expert on psychedelics Peter H. Addy, PhD, LPC, LMHC, reveals How Psychedelic-Assisted Therapy with MDMA Promotes Post-Traumatic Growth.
Discover how MDMA and other psychedelics can help treat mental health distress!
Learn to Confidently Practice Psychedelic-Assisted Therapy
This self-paced online training is your gateway to the new frontier of therapy.
You’ll discover how these medicines work in the body and brain, interventions grounded in neuroscience, how to translate the cutting-edge research into clinically relevant strategies you can apply in your practice right now, and so much more!
Get the skills and confidence to use these medicines to help clients achieve deep and lasting transformation.
You’ll discover how these medicines work in the body and brain, interventions grounded in neuroscience, how to translate the cutting-edge research into clinically relevant strategies you can apply in your practice right now, and so much more!
Get the skills and confidence to use these medicines to help clients achieve deep and lasting transformation.
Meet the Expert:
Peter H. Addy, PhD, LPC, LMHC, has studied psychedelic substances and states and consciousness for 15 years. He earned a PhD in clinical psychology studying transcendence, wholeness, and transformation and conducted one of the earliest studies of the atypical psychedelic plant Salvia divinorum in humans. He continued refining his research and clinical skills at Yale University where he studied Salvia and other atypical psychedelics and co-founded the Yale Psychedelic Science Group. He has completed postdoctoral training in substance use disorder treatment, participated in non-directive harm reduction and integration training at Burning Man, and traveled to Mexico to learn about indigenous use of psychedelic plants among the Mazatec people. He is currently a psychotherapist in private practice in Washington and Oregon.
Dr. Addy has presented internationally on a variety of subjects related to spirituality and transpersonal states, psychedelic science, and research methodology. Participants consistently regarded his talks as informative, accessible, and humorous. He has written numerous scientific articles, book chapters, and popular press articles on typical and atypical psychedelics, substance abuse, and spirituality.
Learn more about their educational products, including upcoming live seminars, by clicking here.
Dr. Addy has presented internationally on a variety of subjects related to spirituality and transpersonal states, psychedelic science, and research methodology. Participants consistently regarded his talks as informative, accessible, and humorous. He has written numerous scientific articles, book chapters, and popular press articles on typical and atypical psychedelics, substance abuse, and spirituality.
Learn more about their educational products, including upcoming live seminars, by clicking here.
